Poland· PL-100316444
Scintimun
A 99mtc-technetium-antigranulozyten antikörper product containing besilesomabum, registered in Poland by Telix Innovations. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
99mtc-technetium-antigranulozyten antikörper is registered in 9 of 19 countries.
Countries holding a registration under ATC V09HA03 (99mtc-technetium-antigranulozyten antikörper), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
99mtc-technetium-antigranulozyten antikörper · ATC V09HA03
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Besilesomabum
- Manufacturer
- Telix Innovations
- Country
- Poland (PL)
- ATC code
- V09HA03
- ATC class
- 99mTc-Technetium-Antigranulozyten Antikörper
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
99mtc-technetium-antigranulozyten antikörper in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSCINTIMUNTelix Innovations, Herstal
- BelgiumScintimun 1 mgTelix Innovations
- SpainSCINTIMUN 1 mg, EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICATelix Innovations
- United KingdomScintimun 1mg kit for radiopharmaceutical preparationCurium Pharma UK Ltd
- SwedenScintimun 1 mg Beredningssats för radioaktivt läkemedelTelix Innovations
- SwitzerlandScintimun, Markierungsbesteckb.e.imaging.ag
- FinlandScintimunTelix Innovations
- FranceSCINTIMUN 1 mg trousse pour préparation radiopharmaceutiqueTELIX INNOVATIONS (BELGIQUE)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Scintimun
- Liechtenstein · Scintimun
- Norway · Scintimun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6e07167b-72cb-40e9-9689-0143f6a34fd8 GET /v1/drugs/6e07167b-72cb-40e9-9689-0143f6a34fd8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zestaw do sporządzania preparatu radiofarmaceutycznego",
"source": "urpl",
"strength": "1 mg",
"packaging": "Rpz ¦ EU/1/09/602/002 ¦ 91573\n2 fiol. 1 mg proszku ¦ 2 fiol. 2,82 mg rozp.\nRpz ¦ EU/1/09/602/001 ¦ 91574\n1 fiol. 1 mg proszku ¦ 1 fiol. 2,82 mg rozp.",
"substance": "Besilesomabum 1 mg",
"common_name": "Besilesomabum",
"pl_product_id": "100316444",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about 99mtc-technetium-antigranulozyten antikörper.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.